Edition:
United States

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

14.76USD
22 Jun 2018
Change (% chg)

$-0.13 (-0.87%)
Prev Close
$14.89
Open
$14.85
Day's High
$14.92
Day's Low
$14.24
Volume
3,037,849
Avg. Vol
265,142
52-wk High
$26.05
52-wk Low
$10.09

Select another date:

Thu, May 3 2018

BRIEF-Glycomimetics Reports Qtrly Loss Per Share Of $0.33

* GLYCOMIMETICS INC - AS OF MARCH 31, 2018, GLYCOMIMETICS HAD CASH AND CASH EQUIVALENTS OF $242.6 MILLION AS COMPARED TO $123.9 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

BRIEF-GlycoMimetics Announces Proposed Public Offering Of Common Stock

* GLYCOMIMETICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Glycomimetics Reports Q4 Loss Per Share $0.27

* GLYCOMIMETICS REPORTS FOURTH QUARTER AND YEAR-END 2017 RESULTS

BRIEF-Glycomimetics Enters Agreement With Hovon To Initiate Study Startup Activities For Planned Clinical Trial Of GMI-1271 And Decitabine

* GLYCOMIMETICS ENTERS INTO AGREEMENT WITH HOVON TO INITIATE STUDY STARTUP ACTIVITIES FOR PLANNED CLINICAL TRIAL OF GMI-1271 AND DECITABINE IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) WHO ARE UNFIT FOR CHEMOTHERAPY

Select another date: